CHICAGO--(BUSINESS WIRE)--CytoCore Inc. (OTCBB:CYOE),
the biopharmaceutical research and medical device company for early
detection and treatment of reproductive-tract cancers, announced that
effective at 9:00 AM EST today, CytoCore shares will trade under the
symbol CYOE. CytoCore has approximately 35,280,000 outstanding.
“We have worked diligently to establish
CytoCore as an institutional grade investment,”
said Robert McCullough, CEO of CytoCore. “Our
initial global product launch is imminent which will increase our
credibility with institutional investors.”
About CytoCore Inc.
CytoCore develops cost-effective cancer screening systems, which can be
utilized in a laboratory or at the point-of-care, to assist in the early
detection of cervical, endometrial, and other cancers. The CytoCore
Solutions™ system is being developed to
provide medical practitioners with highly accurate, low-cost, cervical
and uterine cancer screening systems that can be seamlessly integrated
into existing medical models. More information is available at: www.CytoCoreInc.com.
Certain statements in this release are forward-looking. These statements
are based on CytoCore's current expectations and involve many risks and
uncertainties, such as the company's inability to obtain sufficient
financing, the possibility that clinical trials will not substantiate
CytoCore's expectations with respect to the Core Solutions™
system, and other factors set forth in reports and documents filed by
CytoCore with the Securities and Exchange Commission. Actual results may
differ materially from CytoCore's current expectation depending upon a
number of factors affecting the Company's business. These factors
include, among others, risks and uncertainties detailed in the Company's
periodic public filings with the Securities and Exchange Commission,
including but not limited to the Company's Annual Report on Form 10-K
for the year ended December 31, 2006. Except as expressly required by
law, CytoCore undertakes no obligation to publicly update or revise any
forward-looking statements contained herein.
